Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.177.51NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.17NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.28NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XRNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.350.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBF.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.343NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.4.17 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.25.1.2 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.409NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.83NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.310NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.362.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.162NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Y.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.38.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XAVNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BE.1.4.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBC.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BM.4.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.20NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.77NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CP.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FC.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BY.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BR.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.2.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CP.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BE.4.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.41NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CA.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.26NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.51NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CA.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BM.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.46NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CU.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CA.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.83NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.40NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.27NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.4.2.4 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-18756.6US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used